Florin® Forte (Capsules, Powder) Instructions for Use
ATC Code
A07FA (Antidiarrheal microorganisms)
Active Substances
Bifidobacterium bifidum (Group Group name)
Lactobacillus plantarum (Group Group name)
Clinical-Pharmacological Group
Drug regulating the balance of intestinal microflora (probiotic)
Pharmacotherapeutic Group
MIBP-eubiotic
Pharmacological Action
Bifidobacteria preserve and improve the physiological balance of the intestinal microflora and restore the deficiency of bifidobacteria; exhibit antagonistic activity against a wide range of pathogenic and opportunistic microorganisms; neutralize toxic metabolic products; promote the absorption of minerals (including iron), proteins, carbohydrates; possess vitamin-forming activity, particularly of B vitamins; prevent the formation of protracted forms of intestinal infections; increase the body’s nonspecific resistance.
Lactobacilli are an important component of the normal microflora of the digestive and genital tracts of mammals. They possess diverse biological properties and actively participate in metabolic and regulatory processes. They exhibit pronounced antagonistic activity against a wide range of aerobic and facultative anaerobic gram-negative and gram-positive bacteria, as well as some obligate anaerobic microorganisms. This activity is most pronounced in representatives of the species Lactobacillus acidophilus, L. plantarum, L. casei, L. fermentii, L. buchneri.
Bifidobacteria and lactobacilli, interacting synergistically, maintain and regulate the physiological balance of the intestinal microflora, increasing the resistance of the intestinal mucosa to pathogenic microorganisms; inhibit the translocation of pathogenic bacteria in the colon, possess antagonistic activity against many pathogenic and opportunistic microorganisms, and normalize immunity indicators when it is suppressed.
Indications
Diseases accompanied by a disturbance of the normal intestinal microflora with a deficiency of bifidobacteria, lactobacilli, or normal Escherichia coli; acute intestinal infections caused by rotaviruses and/or opportunistic microflora; acute intestinal infections of unknown etiology; acute respiratory diseases of both viral and microbial origin; chronic gastrointestinal diseases, including those with identified hemolytic Escherichia coli and associations of opportunistic microorganisms in high titers; restoration of normal intestinal flora during the convalescence period after illnesses; dysbacteriosis of various etiologies.
ICD codes
| ICD-10 code | Indication |
| A04 | Other bacterial intestinal infections |
| A05 | Other bacterial food poisonings, not elsewhere classified |
| A08.0 | Rotaviral enteritis |
| A09.0 | Other and unspecified gastroenteritis and colitis of infectious origin (infectious diarrhea NOS) |
| J06.9 | Acute upper respiratory infection, unspecified |
| K52.9 | Noninfective gastroenteritis and colitis, unspecified |
| K63.8 | Other specified diseases of intestine |
| Z54 | Convalescence |
| ICD-11 code | Indication |
| 1A01 | Intestinal infection caused by other Vibrio species |
| 1A03.Z | Intestinal infections caused by Escherichia coli, unspecified |
| 1A0Z | Bacterial intestinal infections, unspecified |
| 1A1Z | Bacterial foodborne intoxications, unspecified |
| 1A22 | Gastroenteritis due to Rotavirus |
| 1A40.Z | Infectious gastroenteritis or colitis, unspecified |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| DA90.0 | Syndromic diarrhea |
| DA92.1 | Pneumatosis intestinalis of the small intestine |
| DA98.Z | Polyps of small intestine, unspecified |
| DB31.1 | Pneumatosis of the colon |
| DB36.Z | Certain infections of the colon, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
| QB7Z | Convalescence, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally.
Determine the dose and duration individually based on the patient’s age, clinical condition, and the specific formulation prescribed.
For the capsule formulation, swallow whole with a sufficient amount of liquid.
For the powder formulation, mix the contents of the sachet with a small volume of cool or lukewarm water (not exceeding 40°C) immediately before use and ingest the resulting suspension.
For acute intestinal infections and acute respiratory diseases, initiate therapy at the first signs of illness.
For chronic gastrointestinal diseases and dysbiosis, follow the course prescribed by the physician.
To restore normal intestinal flora during convalescence, continue use as directed after the acute phase of illness has resolved.
Do not dissolve the powder in hot liquids.
Do not store the reconstituted suspension.
Avoid concomitant administration with antibiotics; if unavoidable, administer the probiotic at the maximum possible time interval from the antibiotic dose.
Adverse Reactions
Possible: allergic reactions, nausea.
Contraindications
Hypersensitivity to the components of the drug used.
Use in Pregnancy and Lactation
The possibility of use during pregnancy and lactation (breastfeeding) depends on the dosage form used.
Special Precautions
Concomitant use with antibiotics is not recommended, nor is dissolving the drug in hot water (above 40°C) or storing it in dissolved form.
Drug Interactions
The action of drugs containing Bifidobacterium bifidum is enhanced by vitamins (especially B vitamins) and reduced by antibiotics.
Storage Conditions
Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Powder for oral administration 50 million CFU+50 million CFU: sachets 10, 20, or 30 pcs.
Marketing Authorization Holder
Avan-Bio, LLC (Russia)
Manufactured By
Probiofarm, LLC (Russia)
Dosage Form
| Florin® Forte | Powder for oral administration 50 million CFU+50 million CFU: sachets 10, 20, or 30 pcs. |
Dosage Form, Packaging, and Composition
Powder for oral administration light gray or dark gray in color with black specks, with a faint fermented milk odor.
| 1 sachet | |
| Bifidobacterium bifidum (sorbed on activated charcoal) | Not less than 50 million CFU |
| Lactobacillus plantarum | Not less than 50 million CFU |
Excipients : lactose monohydrate – up to 0.85 g.
Sachets made of multilayer metal-polymer material (10) – cardboard packs.
Sachets made of multilayer metal-polymer material (20) – cardboard packs.
Sachets made of multilayer metal-polymer material (30) – cardboard packs.
Capsules 50 million CFU+50 million CFU: 10, 15, 20 or 30 pcs.
Marketing Authorization Holder
Avan-Bio, LLC (Russia)
Manufactured By
Probiofarm, LLC (Russia)
Dosage Form
| Florin® forte | Capsules 50 million CFU+50 million CFU: 10, 15, 20 or 30 pcs. |
Dosage Form, Packaging, and Composition
Capsules hard gelatin, white body, yellow cap; capsule contents – powder light gray or dark gray in color with black specks, with a faint fermented milk odor.
| 1 sachet | |
| Bifidobacteria B. bifidum No. 1, sorbed on activated carbon | Not less than 50 million CFU* |
| Lactobacilli L. plantarum 8P-A3 | Not less than 50 million CFU* |
* CFU – colony-forming unit.
Excipients : components of the drying medium (sucrose-gelatin): sucrose – 8.08-8.24 mg, gelatin – 1.07-1.09 mg, activated charcoal – 2.73-2.79 mg, magnesium stearate – 1-10 mg, lactose monohydrate – up to 0.2 g.
Capsule shell composition capsule body – titanium dioxide (white color) 1.0-2.0%, gelatin up to 100%; capsule cap – titanium dioxide 1.0-2.0%, iron oxide (yellow color) 0.05-1.8%, gelatin up to 100%.
10 pcs. – polymer jars (1) – cardboard packs.
15 pcs. – polymer jars (1) – cardboard packs.
20 pcs. – polymer jars (1) – cardboard packs.
30 pcs. – polymer jars (1) – cardboard packs.
